5-Amino-1MQ 5MG
$120.00
5-Amino-1MQ 5MG is a 5-milligram format of 5-Amino-1MQ, a small molecule commonly used in research as an NNMT inhibitor. Researchers study NNMT inhibition in the context of cellular NAD metabolism, methylation pathways, and metabolic regulation. Studies have examined 5-Amino-1MQ in preclinical systems focused on adipose biology and energy balance.
In Stock
5-Amino-1MQ 5MG is a 5-milligram format of 5-Amino-1MQ, a small molecule widely referenced in research involving nicotinamide N-methyltransferase (NNMT) inhibition. NNMT is a cytosolic enzyme that catalyzes the methylation of nicotinamide, connecting nicotinamide handling to broader methyl-donor and NAD related pathways.
In laboratory settings, 5-Amino-1MQ 5MG is of interest for studies examining how NNMT activity may relate to metabolic signaling, adipocyte function, and cellular energetics in preclinical models. Researchers also use NNMT inhibitors to probe links between nicotinamide metabolism and epigenetic methylation capacity, depending on the experimental system.
- Specification: 5MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of two peptide research compounds: cagrilintide (an amylin analogue) and semaglutide (a GLP 1 receptor agonist peptide analogue). Researchers study this pairing in preclinical and clinical research settings focused on appetite regulation and metabolic signaling. Studies have examined how amylin and GLP 1 pathways may interact when investigated together.
In Stock
Semaglutide 10MG is a 10-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. Researchers study semaglutide in receptor pharmacology and metabolic signaling research, including models examining appetite regulation and glucose homeostasis. It is also used in assay development and method validation where GLP 1 pathway engagement is of interest.
In Stock
Tirzepatide 30MG is a 30-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glucose regulation pathways, and energy balance models.
In Stock
Trenbolone Base 50mg ml 10ml refers to trenbolone in a 50 mg per mL concentration across a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from the 19 nor testosterone scaffold. Researchers have used trenbolone as a reference compound in studies involving androgen receptor signaling and anabolic steroid structure activity relationships.
In Stock
Semaglutide 20MG is a 20 milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is a 31 amino acid peptide modified for extended stability, and it is widely used in laboratory work involving incretin signaling and metabolic regulation. Researchers study semaglutide in preclinical and translational settings related to glucose homeostasis, appetite pathways, and receptor pharmacology.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
Trenbolone Enanthate 250Mg; Drostanolone Enanthate 250Mg – 500mg/ml, 10ml is a combined format of two anabolic androgenic steroid esters: trenbolone (a 19 nor testosterone derivative) and drostanolone (a DHT derived analogue). Researchers may reference these compounds in studies involving androgen receptor signaling, esterified steroid pharmacokinetics, and analytical method development. Work in the literature commonly discusses trenbolone and drostanolone in the context of endocrine pathways and structure activity relationships.
In Stock
Trenbolone Enanthate (Tre) 200mg/ml 10ml is a concentration and volume format of trenbolone enanthate, a synthetic anabolic androgenic steroid and esterified analogue of trenbolone. Researchers may use trenbolone esters in laboratory work involving androgen receptor signaling, steroid metabolism, and analytical reference testing.
In Stock
Tirzepatide 10MG is a 10-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glycemic physiology, and energy balance pathways.
In Stock
Trenbolone Enanthate 125Mg; Drostanolone Enanthate 125Mg; Testosterone Enanthate 125Mg – 500mg/ml, 10ml is a multi compound anabolic androgenic steroid preparation featuring three long ester derivatives of trenbolone, drostanolone, and testosterone. Researchers may reference this combination when examining androgen receptor driven signaling, ester linked pharmacokinetics, and analytical detection methods in complex steroid mixtures. Studies have also considered how mixed esterified steroids behave in chromatography and mass spectrometry workflows.
In Stock
Cagrilintide 10MG is a 10-milligram format of cagrilintide, a long acting amylin analogue peptide designed to engage amylin receptor pathways. Researchers study cagrilintide in preclinical and translational settings involving appetite signalling, gastric emptying models, and metabolic regulation.
In Stock
Semaglutide 30MG is a 30-milligram format of semaglutide, a synthetic GLP-1 receptor agonist peptide analogue. Researchers study semaglutide in the context of incretin signaling, glucose regulation pathways, and appetite related neuroendocrine models. It is a modified peptide designed to extend stability relative to native GLP-1.
In Stock
